Evaluation of Pulpal Biomarkers in Vital Pulp Therapy (NCT07073573) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evaluation of Pulpal Biomarkers in Vital Pulp Therapy
Turkey (Türkiye)50 participantsStarted 2025-03-03
Plain-language summary
This prospective clinical study aims to evaluate the association between the levels of selected pulpal biomarkers and the clinical success of vital pulp therapy in permanent teeth. Patients undergoing vital pulp therapy will be monitored over time, and biomarker expression levels will be analyzed in relation to treatment outcomes. The study intends to provide insight into the predictive value of pulp tissue biomarkers for long-term success in vital pulp procedures.
Who can participate
Age range
16 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Permanent teeth diagnosed with reversible pulpitis
* Patients diagnosed with irreversible pulpitis but without apical radiolucency
* Teeth showing a normal response to cold testing (carbon dioxide snow)
* Teeth with irreversible pulpitis demonstrating prolonged response to cold testing
* Teeth with no sensitivity to percussion or chewing
* In teeth with exposed pulp tissue, bleeding time less than 5 minutes
* In irreversible pulpitis cases, bleeding time less than 10 minutes
* No widening of the periodontal ligament space (periapical index \[PAI\] ≤ 2)
* Radiographic evidence of deep dentinal caries
Exclusion Criteria:
* Teeth with a negative response to cold testing (carbon dioxide snow)
* Presence of apical radiolucency (PAI \> 2)
* Condensed apical periodontitis
* Internal or external root resorption
* History of dental trauma
* Longitudinal root fracture
* Presence of periodontal-endodontic lesions on the day of treatment
* Functional loss (e.g., Grade 3 tooth mobility)
* Swelling associated with the treated tooth
* Teeth that cannot be treated under rubber dam isolation
* Teeth from which less than 2.5 mL of pulpal blood can be collected
* Immunocompromised individuals
* Pregnant women at the time of treatment
* Use of antibiotics, bisphosphonates, or statins within 4 weeks prior to treatment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Clinical success of treated teeth with Vital Pulp Therapy